Immunovant, Inc.: CEO Venker Eric exercised 92,187 shares

What happened

• Venker Eric, CEO, exercised 92,187 capped value appreciation rights (CVARs) into common stock on Oct 1, 2026. The filing shows acquisition of 92,187 shares at $14.46 per share for $1,333,024 and sales of 85,886 shares to the issuer at $33.65 for $2,890,064 and 3,506 shares in an open-market sale at $34.11 for $119,590. The CVAR settlement is also reported as a derivative disposition of 92,187 shares at $0.00.

Key details

• Transaction dates and prices:
  • Oct 1, 2026: exercised/converted 92,187 CVARs into 92,187 shares at $14.46 (total $1,333,024).
  • Oct 1, 2026: sold 85,886 shares to the issuer at $33.65 (total $2,890,064) to satisfy tax withholding.
  • Oct 2, 2026: sold 3,506 shares in the open market at $34.11 (total $119,590).
• Shares sold total: 89,392 shares for $3,009,654.
• Shares owned after the transactions: not stated in the filing.
• Relevant footnotes from the filing:
  • F1: CVARs granted Jul 28, 2025; payoff equals vested CVARs times excess of market value (capped at $16.76) over a $14.46 hurdle, then settled into shares.
  • F2: On Oct 1, 2026, the applicable requirements were satisfied for 92,187 vested CVARs and they were settled into shares using the Oct 1, 2026 closing price.
  • F3: The sale of 85,886 shares was a mandatory "sell to cover" to satisfy tax withholding and was not a discretionary sale by the reporting person.
  • F4: Vesting schedule and conditions: 25% vested Apr 1, 2026, remaining 75% in 12 quarterly installments; performance and knock-in conditions described in the filing.
• Filing date: filed Oct 5, 2026, reporting transactions on Oct 1 and Oct 2, 2026. The filing does not indicate a late filing.

Why it may matter

• The filing shows exercise/settlement of CVARs and sales to cover taxes plus an open-market sale; the sale to the issuer was a mandated sell to cover tax withholding rather than a discretionary market sale.
• The filing does not show why the insider traded or why the company acted.